Karuna Therapeutics, Inc.
KRTX · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $186 | $184 | $264 | $563 |
| Short-Term Investments | $1,077 | $1,157 | $1,173 | $910 |
| Receivables | $5 | $5 | $0 | $0 |
| Inventory | $33 | $7 | $0 | $0 |
| Other Curr. Assets | $15 | $11 | $7 | $35 |
| Total Curr. Assets | $1,315 | $1,365 | $1,452 | $1,508 |
| Property Plant & Equip (Net) | $21 | $19 | $20 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | -$2 | -$2 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $2 | $3 | $0 |
| Total NC Assets | $21 | $20 | $20 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,336 | $1,385 | $1,472 | $1,516 |
| Liabilities | – | – | – | – |
| Payables | $7 | $3 | $1 | $0 |
| Short-Term Debt | $3 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $42 | $44 | $0 | $0 |
| Other Curr. Liab. | $17 | $0 | $36 | $23 |
| Total Curr. Liab. | $68 | $49 | $39 | $25 |
| LT Debt | $14 | $14 | $14 | $3 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $14 | $14 | $14 | $3 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $82 | $63 | $53 | $28 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$998 | -$884 | -$765 | -$662 |
| AOCI | $0 | -$3 | -$4 | -$2 |
| Other Equity | $2,252 | $2,209 | $2,188 | $2,152 |
| Total Equity | $1,254 | $1,322 | $1,420 | $1,488 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,336 | $1,385 | $1,472 | $1,516 |
| Net Debt | -$169 | -$169 | -$248 | -$558 |